{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:18:06Z","timestamp":1790839086618,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"University of Hong Kong Small Project Funding","award":["201409176201"],"award-info":[{"award-number":["201409176201"]}]},{"name":"Department of Medicine Academic Activities Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We investigated circulating syndecan-1, HA and thrombomodulin levels in patients with biopsy-proven Class III\/IV\u2009\u00b1\u2009V LN and their clinico-pathological associations. Patients with non-renal SLE or non-lupus chronic kidney disease, and healthy subjects served as controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum syndecan-1, HA and thrombomodulin levels were determined by ELISAs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Syndecan-1, HA and thrombomodulin levels were significantly higher during active LN compared with remission (P\u2009&amp;lt;\u20090.01, for all), and correlated with the level of proteinuria, estimated glomerular filtration rate, anti-dsDNA antibodies, complement 3 and serum creatinine. Longitudinal studies showed that syndecan-1 and thrombomodulin levels increased prior to clinical renal flare by 3.6\u2009months, while HA level increased at the time of nephritic flare, and the levels decreased in parallel with treatment response. Receiver operating characteristic curve analysis showed that syndecan-1 and thrombomodulin levels distinguished patients with active LN from healthy subjects, LN patients in remission, patients with active non-renal lupus and patients with non-lupus chronic kidney disease (receiver operating characteristic area under curve of 0.98, 0.91, 0.82 and 0.95, respectively, for syndecan-1; and area under curve of 1.00, 0.84, 0.97 and 0.79, respectively, for thrombomodulin). HA level distinguished active LN from healthy subjects, LN patients in remission and non-lupus chronic kidney disease (receiver operating characteristic area under curve of 0.82, 0.71 and 0.90, respectively) but did not distinguish between renal vs non-renal lupus. Syndecan-1 and thrombomodulin levels correlated with the severity of interstitial inflammation, while HA level correlated with chronicity grading in kidney biopsies of active LN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our findings suggest potential utility of serum syndecan-1, thrombomodulin and HA levels in clinical management, and their potential contribution to LN pathogenesis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa370","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:11:44Z","timestamp":1591096304000},"page":"737-750","source":"Crossref","is-referenced-by-count":21,"title":["Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis"],"prefix":"10.1093","volume":"60","author":[{"given":"Kelvin Y C","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Yung","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel K M","family":"Chau","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin S O","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond Y H","family":"Yap","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H N","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley K Y","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk Kwong","family":"Lee","sequence":"additional","affiliation":[{"name":"Hong Kong Red Cross Blood Transfusion Service, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-4051","authenticated-orcid":false,"given":"Tak Mao","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"2021020119060606900_keaa370-B1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrneph.2014.215","article-title":"Treatment of severe lupus nephritis: the new horizon","volume":"11","author":"Chan","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2021020119060606900_keaa370-B2","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3912","article-title":"Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis","volume":"14","author":"Singh","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021020119060606900_keaa370-B3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2016.06.010","article-title":"Urinary biomarkers in childhood lupus nephritis","volume":"185","author":"Smith","year":"2017","journal-title":"Clin Immunol"},{"key":"2021020119060606900_keaa370-B4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/kem112","article-title":"Fifty years of anti-ds DNA antibodies: are we approaching journey\u2019s end?","volume":"46","author":"Isenberg","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2021020119060606900_keaa370-B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ndt\/gfy024","article-title":"Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study","volume":"34","author":"Yap","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2021020119060606900_keaa370-B6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13075-017-1442-6","article-title":"Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review","volume":"19","author":"Gensous","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2021020119060606900_keaa370-B7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0961203316684212","article-title":"Prospective validation of a novel renal activity index of lupus nephritis","volume":"26","author":"Gulati","year":"2017","journal-title":"Lupus"},{"key":"2021020119060606900_keaa370-B8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2011.10.001","article-title":"Molecular functions of syndecan-1 in disease","volume":"31","author":"Teng","year":"2012","journal-title":"Matrix Biol"},{"key":"2021020119060606900_keaa370-B9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/77108","article-title":"Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice","volume":"25","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"2021020119060606900_keaa370-B10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2215\/CJN.08160813","article-title":"Association of kidney function with changes in the endothelial surface layer","volume":"9","author":"Dane","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020119060606900_keaa370-B11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ki.1997.99","article-title":"Thrombomodulin is synthesized by human mesangial cells","volume":"51","author":"Pruna","year":"1997","journal-title":"Kidney Int"},{"key":"2021020119060606900_keaa370-B12","doi-asserted-by":"crossref","first-page":"33003","DOI":"10.1074\/jbc.M111.279174","article-title":"Involvement of human natural killer-1 (HNK-1) sulfotransferase in the biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl tetrasaccharide found in alpha-thrombomodulin from human urine","volume":"286","author":"Hashiguchi","year":"2011","journal-title":"J Biol Chem"},{"key":"2021020119060606900_keaa370-B13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0038-1657557","article-title":"Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis","volume":"78","author":"Nesheim","year":"1997","journal-title":"Thromb Haemost"},{"key":"2021020119060606900_keaa370-B14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","article-title":"Fibroblasts and myofibroblasts in renal fibrosis","volume":"92","author":"Meran","year":"2011","journal-title":"Int J Exp Pathol"},{"key":"2021020119060606900_keaa370-B15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrneph.2010.65","article-title":"Endothelial activation and circulating markers of endothelial activation in kidney disease","volume":"6","author":"Rabelink","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"2021020119060606900_keaa370-B16","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1681\/ASN.2011121181","article-title":"Damage of the endothelial glycocalyx in dialysis patients","volume":"23","author":"Vlahu","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2021020119060606900_keaa370-B17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2015.162","article-title":"The glycocalyx\u2014linking albuminuria with renal and cardiovascular disease","volume":"11","author":"Rabelink","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2021020119060606900_keaa370-B18","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1097\/TP.0000000000002170","article-title":"Syndecan-1 shedding inhibition to protect against ischemic acute kidney injury through HGF target signaling pathway","volume":"102","author":"Lu","year":"2018","journal-title":"Transplantation"},{"key":"2021020119060606900_keaa370-B19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","article-title":"Exploring traditional and nontraditional roles for thrombomodulin","volume":"132","author":"Loghmani","year":"2018","journal-title":"Blood"},{"key":"2021020119060606900_keaa370-B20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/03009742.2019.1577490","article-title":"Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome","volume":"48","author":"Hellman","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2021020119060606900_keaa370-B21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.matbio.2018.09.003","article-title":"Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control","volume":"80","author":"Nagy","year":"2019","journal-title":"Matrix Biol"},{"key":"2021020119060606900_keaa370-B22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ncprheum0655","article-title":"Tobacco smoking and autoimmune rheumatic diseases","volume":"3","author":"Harel-Meir","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2021020119060606900_keaa370-B23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2021020119060606900_keaa370-B24","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3899\/jrheum.180507","article-title":"Longterm data on sirolimus treatment in patients with lupus nephritis","volume":"45","author":"Yap","year":"2018","journal-title":"J Rheumatol"},{"key":"2021020119060606900_keaa370-B25","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.4049\/jimmunol.179.10.7166","article-title":"Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis","volume":"179","author":"Wu","year":"2007","journal-title":"J Immunol"},{"key":"2021020119060606900_keaa370-B26","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2021020119060606900_keaa370-B27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome","volume":"25","author":"Austin","year":"1984","journal-title":"Kidney Int"},{"key":"2021020119060606900_keaa370-B28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"Haraldsson","year":"2008","journal-title":"Physiol Rev"},{"key":"2021020119060606900_keaa370-B29","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1681\/ASN.2007010119","article-title":"Glomerular endothelial glycocalyx constitutes a barrier to protein permeability","volume":"18","author":"Singh","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021020119060606900_keaa370-B30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.kint.2019.05.007","article-title":"Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells","volume":"96","author":"Ebefors","year":"2019","journal-title":"Kidney Int"},{"key":"2021020119060606900_keaa370-B31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1152\/physrev.00052.2009","article-title":"Hyaluronan as an immune regulator in human diseases","volume":"91","author":"Jiang","year":"2011","journal-title":"Physiol Rev"},{"key":"2021020119060606900_keaa370-B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1619293","article-title":"Thrombomodulin as a new marker of endothelial dysfunction in chronic kidney disease in children","volume":"2018","author":"Dro\u017cd\u017c","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"2021020119060606900_keaa370-B33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2215\/CJN.08780816","article-title":"Use of proteomics to investigate kidney function decline over 5 years","volume":"12","author":"Carlsson","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020119060606900_keaa370-B34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/ard.2008.094508","article-title":"Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis","volume":"68","author":"Moroni","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021020119060606900_keaa370-B35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-017-1498-3","article-title":"Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis","volume":"20","author":"Mok","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021020119060606900_keaa370-B36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08916934.2010.545846","article-title":"Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus","volume":"44","author":"Minowa","year":"2011","journal-title":"Autoimmunity"},{"key":"2021020119060606900_keaa370-B37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3899\/jrheum.140568","article-title":"Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus","volume":"42","author":"Kim","year":"2015","journal-title":"J Rheumatol"},{"key":"2021020119060606900_keaa370-B38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2016.11.005","article-title":"Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients","volume":"181","author":"Mosaad","year":"2017","journal-title":"Immunol Lett"},{"key":"2021020119060606900_keaa370-B39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2249.2000.01107.x","article-title":"Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity","volume":"119","author":"Boehme","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2021020119060606900_keaa370-B40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/rheumatology\/keg045","article-title":"Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus","volume":"42","author":"Ho","year":"2003","journal-title":"Rheumatology (Oxford"},{"key":"2021020119060606900_keaa370-B41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/0961203308089441","article-title":"Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis","volume":"17","author":"Yao","year":"2008","journal-title":"Lupus"},{"key":"2021020119060606900_keaa370-B42","first-page":"514","article-title":"Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers","volume":"28","author":"Frijns","year":"2001","journal-title":"J Rheumatol"},{"key":"2021020119060606900_keaa370-B43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.ki.5000042","article-title":"Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta","volume":"69","author":"Yung","year":"2006","journal-title":"Kidney Int"},{"key":"2021020119060606900_keaa370-B44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0961203319897958","article-title":"New insights into antiphospholipid-related endothelial dysfunction by assessment of vascular glycocalyx layer: results from a preliminary cross-sectional study","volume":"29","author":"Miranda","year":"2020","journal-title":"Lupus"},{"key":"2021020119060606900_keaa370-B45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2018.12.022","article-title":"Syndecan-1 as an independent risk factor for the incidence of adverse cardiovascular events in patients having stage C and D heart failure with non-ischemic dilated cardiomyopathy","volume":"490","author":"Liu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2021020119060606900_keaa370-B46","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0272-6386(99)70014-4","article-title":"High serum hyaluronan indicates poor survival in renal replacement therapy","volume":"34","author":"Stenvinkel","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2021020119060606900_keaa370-B47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/oxfordjournals.ndt.a027074","article-title":"Serum hyaluronan concentrations predict survival in patients with chronic renal failure on maintenance haemodialysis","volume":"11","author":"Woodrow","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2021020119060606900_keaa370-B48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/ndt\/gfh663","article-title":"Serum albumin: a late-reacting negative acute-phase protein in clinically evident inflammation in dialysis patients","volume":"20","author":"Tsirpanlis","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2021020119060606900_keaa370-B49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.11418","article-title":"Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus","volume":"50","author":"Selzer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021020119060606900_keaa370-B50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ki.2011.425","article-title":"Tubular epithelial syndecan-1 maintains renal function in murine ischemia\/reperfusion and human transplantation","volume":"81","author":"Celie","year":"2012","journal-title":"Kidney Int"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/737\/36167782\/keaa370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/737\/36167782\/keaa370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T03:42:01Z","timestamp":1612323721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/737\/5892439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa370","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,8,13]]}}}